Current Report Filing (8-k)
June 25 2014 - 9:03AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
June 17, 2014
ALLIED
HEALTHCARE PRODUCTS, INC.
(Exact name of registrant as specified in its charter)
Delaware |
0-19266 |
25-1370721 |
(State or Other Jurisdiction
of Incorporation) |
(Commission
File Number) |
(IRS Employer
Identification No.) |
1720 Sublette Avenue, St. Louis, Missouri
(Address of principal executive offices) |
63110
(Zip Code) |
Registrant’s telephone number, including area code |
(314) 771-2400 |
|
Not applicable |
(Former name or former address, if changed since last report) |
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
ITEM 5.02. Departure of Directors or Certain Officers; Election
of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On June 17, 2014, Robert B. Harris, the Vice President of Operations
of Allied Healthcare Products, Inc. (the “Company”), announced
his decision to resign from his position at the Company effective November 15, 2014.
On June 20, 2014, Eldon P. Rosentrater, the Vice President of
Administration & Corporate Planning of the Company, announced his decision to retire from his position at the Company effective
October 20, 2014.
SIGNATURE
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
thereunto duly authorized.
|
ALLIED HEALTHCARE PRODUCTS, INC. |
|
|
|
|
By: |
|
|
|
|
Date: June 25, 2014 |
|
/s/ Daniel C. Dunn |
|
|
Daniel C. Dunn |
|
|
Chief Financial Officer |
Allied Healthcare Products (NASDAQ:AHPI)
Historical Stock Chart
From Sep 2024 to Oct 2024
Allied Healthcare Products (NASDAQ:AHPI)
Historical Stock Chart
From Oct 2023 to Oct 2024